E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/3/2013 in the Prospect News PIPE Daily.

Bio-Path completes $3.22 million private placement of common stock

Biotechnology company sells 8,052,514 shares in offering

By Toni Weeks

San Luis Obispo, Calif., Oct. 3 - Bio-Path Holdings, Inc. completed a private placement of stock on Sept. 30, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 8,052,514 common shares for proceeds of about $3.22 million.

Bio-Path is a Houston-based biotechnology company.

Issuer:Bio-Path Holdings, Inc.
Issue:Common stock
Amount:$3.22 million (approximate)
Shares:8,052,514
Warrants:No
Settlement date:Sept. 30
Stock symbol:OTCBB: BPTH
Stock price:$2.15 at close Oct. 2
Market capitalization:$187.7 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.